SCHEMBL2489698

SCHEMBL2489698

COc1ccc2c(c1)-c1c(cnc3[nH]ncc13)CC2

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TYMS P04818 1/20 0.46
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 2/20 0.42
MAPT P10636 2/20 0.42
HTT P42858 1/20 0.42
PDPK1 O15530 1/20 0.42
MAPK10 P53779 2/20 0.42
RIPK1 Q13546 2/20 0.42
MPI P34949 1/20 0.41
NPY5R Q15761 2/20 0.41
CYP19A1 P11511 4/20 0.40
CYP11B2 P19099 2/20 0.40
BRD4 O60885 1/20 0.39
FYN P06241 1/20 0.39
TIPARP Q7Z3E1 1/20 0.39
METAP2 P50579 1/20 0.39
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
ROCK2 O75116 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2487665 0.90 KDM4E (0.51) KDM4EALDH1A1MAPTHTTPDPK1
SCHEMBL2487133 0.82 BRD4 (0.43) KDM4EALDH1A1MAPTHTTMAPK10
SCHEMBL2486697 0.80 CHEK2 (0.44) TYMSMETAP2
SCHEMBL2487713 0.75 MAPK10 (0.43) KDM4EALDH1A1MAPTMAPK10RIPK1
SCHEMBL2806333 0.74 RPS6KB1 (0.54) KDM4EALDH1A1MAPTROCK2
SCHEMBL2511927 0.71 NFKB1 (0.47) TYMSKDM4EALDH1A1MAPTMAPK10
SCHEMBL2491370 0.71 TYMS (0.42) TYMSKDM4EALDH1A1MAPTPDPK1
SCHEMBL2490172 0.70 CDK9 (0.54) PDPK1ROCK2
SCHEMBL2484446 0.69 HSP90AA1 (0.48) KDM4EMAPTBRD4ROCK2
SCHEMBL7080743 0.68 TYMS (0.57) TYMSKDM4EALDH1A1MAPTMPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8263610-B2 Substituted imidazolyl-5,6-dihydrobenzo[N]isoquinoline compounds ARQULE, INC. (US) 2012-09-11 US disclosed
US-8263610-B2 Substituted imidazolyl-5,6-dihydrobenzo[N]isoquinoline compounds ARQULE, INC. (US) 2012-09-11 US disclosed
US-8263610-B2 Substituted imidazolyl-5,6-dihydrobenzo[N]isoquinoline compounds ARQULE, INC. (US) 2012-09-11 US disclosed
EP-2379551-A1 SUBSTITUTED PYRAZOLO [3, 4-B]PYRIDINE COMPOUNDS ArQule, Inc. (US) 2011-10-26 EP disclosed
US-20100239526-A1 SUBSTITUTED IMIDAZOLYL-5,6-DIHYDROBENZO[N]ISOQUINOLINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
US-20100239526-A1 SUBSTITUTED IMIDAZOLYL-5,6-DIHYDROBENZO[N]ISOQUINOLINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
US-20100239526-A1 SUBSTITUTED IMIDAZOLYL-5,6-DIHYDROBENZO[N]ISOQUINOLINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
WO-2010078427-A1 SUBSTITUTED PYRAZOLO [3, 4-B] PYRIDINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed
WO-2010078427-A1 SUBSTITUTED PYRAZOLO [3, 4-B] PYRIDINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239526-A1 SUBSTITUTED IMIDAZOLYL-5,6-DIHYDROBENZO[N]ISOQUINOLINE COMPOUNDS NQO1, IDH3B, IDH1 TYMS 670/4885KDM4E 1334/4885ALDH1A1 460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.